Cargando…
Sickle cell disease patient plasma sensitizes iPSC-derived sensory neurons from sickle cell disease patients
Individuals living with sickle cell disease (SCD) experience severe recurrent acute and chronic pain. In order to develop novel therapies, it is necessary to better understand the neurobiological mechanisms underlying SCD pain. There are many barriers to gaining mechanistic insight into pathogenic S...
Autores principales: | Allison, Reilly L., Burand, Anthony, Torres, Damaris Nieves, Brandow, Amanda M., Stucky, Cheryl L., Ebert, Allison D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9882050/ https://www.ncbi.nlm.nih.gov/pubmed/36711992 http://dx.doi.org/10.1101/2023.01.10.523446 |
Ejemplares similares
-
COVID-19 Outcomes in Individuals with Sickle Cell Disease and Sickle Cell Trait Compared to Blacks without Sickle Cell Disease or Trait
por: Singh, Ashima, et al.
Publicado: (2020) -
Gut microbiota and metabolites drive chronic sickle cell disease pain
por: Sadler, Katelyn E., et al.
Publicado: (2023) -
Advances in the diagnosis and treatment of sickle cell disease
por: Brandow, A. M., et al.
Publicado: (2022) -
COVID-19 and venous thromboembolism risk in patients with sickle cell disease
por: Singh, Ashima, et al.
Publicado: (2022) -
Peripheral nerve pathology in sickle cell disease mice
por: Sadler, Katelyn E., et al.
Publicado: (2019)